학술논문
CNTO6785, a Fully Human Antiinterleukin 17 Monoclonal Antibody, in Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate: A Randomized, Placebo-controlled, Phase II, Dose-ranging Study.
Document Type
journal article
Author
Source
Journal of Rheumatology; Jan2018, Vol. 45 Issue 1, p22-31, 10p
Subject
Language
ISSN
0315162X